Header Logo

Connection

WILLIAM PEACOCK to Prospective Studies

Back to Details
This is a "connection" page, showing publications WILLIAM PEACOCK has written about Prospective Studies.
WILLIAM PEACOCK
Connection Strength
1.523
Prospective Studies
  1. Remote dielectric sensing for detecting pulmonary edema in the emergency department. Am J Emerg Med. 2022 05; 55:11-15.
    View in: PubMed
    Score: 0.073
  2. The use of the reds noninvasive lung fluid monitoring system to assess readiness for discharge in patients hospitalized with acute heart failure: A pilot study. Heart Lung. 2021 Jan - Feb; 50(1):59-64.
    View in: PubMed
    Score: 0.066
  3. Response to Letter to the Editor. J Emerg Med. 2019 10; 57(4):575.
    View in: PubMed
    Score: 0.062
  4. Real World Evidence for Treatment of Hyperkalemia in the Emergency Department (REVEAL-ED): A Multicenter, Prospective, Observational Study. J Emerg Med. 2018 Dec; 55(6):741-750.
    View in: PubMed
    Score: 0.058
  5. Efficacy of High-Sensitivity Troponin T in Identifying Very-Low-Risk Patients With Possible Acute Coronary Syndrome. JAMA Cardiol. 2018 02 01; 3(2):104-111.
    View in: PubMed
    Score: 0.055
  6. Missed myocardial infarctions in ED patients prospectively categorized as low risk by established risk scores. Am J Emerg Med. 2017 May; 35(5):704-709.
    View in: PubMed
    Score: 0.051
  7. Can a Point-of-Care Troponin I Assay be as Good as a Central Laboratory Assay? A MIDAS Investigation. Ann Lab Med. 2016 Sep; 36(5):405-12.
    View in: PubMed
    Score: 0.050
  8. The management of acute hypertension in patients with renal dysfunction: labetalol or nicardipine? Postgrad Med. 2014 Jul; 126(4):124-30.
    View in: PubMed
    Score: 0.043
  9. Procalcitonin as a biomarker for early sepsis in the emergency department. Eur J Emerg Med. 2014 Apr; 21(2):112-7.
    View in: PubMed
    Score: 0.042
  10. Clevidipine in acute heart failure: Results of the A Study of Blood Pressure Control in Acute Heart Failure-A Pilot Study (PRONTO). Am Heart J. 2014 Apr; 167(4):529-36.
    View in: PubMed
    Score: 0.042
  11. ST2 in emergency department patients with noncardiac dyspnea. Acad Emerg Med. 2013 Nov; 20(11):1207-10.
    View in: PubMed
    Score: 0.041
  12. Copeptin helps in the early detection of patients with acute myocardial infarction: primary results of the CHOPIN trial (Copeptin Helps in the early detection Of Patients with acute myocardial INfarction). J Am Coll Cardiol. 2013 Jul 09; 62(2):150-160.
    View in: PubMed
    Score: 0.040
  13. Identifying patients for early discharge: performance of decision rules among patients with acute chest pain. Int J Cardiol. 2013 Sep 30; 168(2):795-802.
    View in: PubMed
    Score: 0.038
  14. Differentiation of cardiac and noncardiac dyspnea using bioelectrical impedance vector analysis (BIVA). J Card Fail. 2012 Mar; 18(3):226-32.
    View in: PubMed
    Score: 0.036
  15. Myeloperoxidase in the diagnosis of acute coronary syndromes: the importance of spectrum. Am Heart J. 2011 Nov; 162(5):893-9.
    View in: PubMed
    Score: 0.036
  16. Short-term mortality risk in emergency department acute heart failure. Acad Emerg Med. 2011 Sep; 18(9):947-58.
    View in: PubMed
    Score: 0.035
  17. Clevidipine for severe hypertension in acute heart failure: a VELOCITY trial analysis. Congest Heart Fail. 2010 Mar-Apr; 16(2):55-9.
    View in: PubMed
    Score: 0.032
  18. Clevidipine, an intravenous dihydropyridine calcium channel blocker, is safe and effective for the treatment of patients with acute severe hypertension. Ann Emerg Med. 2009 Mar; 53(3):329-38.
    View in: PubMed
    Score: 0.028
  19. Clinical and economic benefits of using AUDICOR S3 detection for diagnosis and treatment of acute decompensated heart failure. Congest Heart Fail. 2006 Jul-Aug; 12 Suppl 1:32-6.
    View in: PubMed
    Score: 0.025
  20. Impact of impedance cardiography on diagnosis and therapy of emergent dyspnea: the ED-IMPACT trial. Acad Emerg Med. 2006 Apr; 13(4):365-71.
    View in: PubMed
    Score: 0.024
  21. International Validation of the Canadian Syncope Risk Score : A Cohort Study. Ann Intern Med. 2022 06; 175(6):783-794.
    View in: PubMed
    Score: 0.019
  22. Effective observation unit treatment of decompensated heart failure. Congest Heart Fail. 2002 Mar-Apr; 8(2):68-73.
    View in: PubMed
    Score: 0.018
  23. Multiple Cardiac Biomarker Testing Among Patients With Acute Dyspnea From the ICON-RELOADED Study. J Card Fail. 2022 02; 28(2):226-233.
    View in: PubMed
    Score: 0.018
  24. Normal CK, elevated MB predicts complications in acute coronary syndromes. J Emerg Med. 2001 May; 20(4):385-90.
    View in: PubMed
    Score: 0.017
  25. Development of an electrocardiogram-based risk calculator for a cardiac cause of syncope. Heart. 2021 11; 107(22):1796-1804.
    View in: PubMed
    Score: 0.017
  26. Biomarkers Enhance Discrimination and Prognosis of Type 2 Myocardial Infarction. Circulation. 2020 10 20; 142(16):1532-1544.
    View in: PubMed
    Score: 0.016
  27. Ideal high sensitivity troponin baseline cutoff for patients with renal dysfunction. Am J Emerg Med. 2021 08; 46:170-175.
    View in: PubMed
    Score: 0.016
  28. External validation of an emergency department triage algorithm for chest pain patients. Eur Heart J Acute Cardiovasc Care. 2020 Sep; 9(6):576-585.
    View in: PubMed
    Score: 0.016
  29. Diagnostic and Prognostic Utilities of Insulin-Like Growth Factor Binding Protein-7 in Patients With Dyspnea. JACC Heart Fail. 2020 05; 8(5):415-422.
    View in: PubMed
    Score: 0.016
  30. The association of long-term outcome and biological sex in patients with acute heart failure from different geographic regions. Eur Heart J. 2020 04 01; 41(13):1357-1364.
    View in: PubMed
    Score: 0.016
  31. Prediction of short- and long-term outcomes by troponin T levels in low-risk patients evaluated for acute coronary syndromes. Ann Emerg Med. 2000 Mar; 35(3):213-20.
    View in: PubMed
    Score: 0.016
  32. Performance of Novel High-Sensitivity Cardiac Troponin I Assays for 0/1-Hour and 0/2- to 3-Hour Evaluations for Acute Myocardial Infarction: Results From the HIGH-US Study. Ann Emerg Med. 2020 07; 76(1):1-13.
    View in: PubMed
    Score: 0.016
  33. Insulin-like Growth Factor Binding Protein 2 predicts mortality risk in heart failure. Int J Cardiol. 2020 02 01; 300:245-251.
    View in: PubMed
    Score: 0.016
  34. Prevalence of Pulmonary Embolism in Patients With Syncope. J Am Coll Cardiol. 2019 08 13; 74(6):744-754.
    View in: PubMed
    Score: 0.015
  35. Myocardial Infarction Risk Stratification With a Single Measurement of High-Sensitivity Troponin I. J Am Coll Cardiol. 2019 07 23; 74(3):271-282.
    View in: PubMed
    Score: 0.015
  36. Circadian, weekly, seasonal, and temperature-dependent patterns of syncope aetiology in patients at increased risk of cardiac syncope. Europace. 2019 Mar 01; 21(3):511-521.
    View in: PubMed
    Score: 0.015
  37. Inflammatory Biomarkers and Clinical Judgment in the Emergency Diagnosis of Urgent Abdominal Pain. Clin Chem. 2019 02; 65(2):302-312.
    View in: PubMed
    Score: 0.015
  38. Prospective validation of prognostic and diagnostic syncope scores in the emergency department. Int J Cardiol. 2018 Oct 15; 269:114-121.
    View in: PubMed
    Score: 0.014
  39. N-Terminal Pro-B-Type Natriuretic Peptide in the Emergency Department: The?ICON-RELOADED Study. J Am Coll Cardiol. 2018 03 20; 71(11):1191-1200.
    View in: PubMed
    Score: 0.014
  40. Prohormones in the Early Diagnosis of Cardiac Syncope. J Am Heart Assoc. 2017 12 14; 6(12).
    View in: PubMed
    Score: 0.014
  41. Improved Assessment of Chest pain Trial (IMPACT): assessing patients with possible acute coronary syndromes. Med J Aust. 2017 Aug 04; 207(5):195-200.
    View in: PubMed
    Score: 0.013
  42. Renal Function and Scaled Troponin in Patients Presenting to the Emergency Department with Symptoms of Myocardial Infarction. Am J Nephrol. 2017; 45(4):304-309.
    View in: PubMed
    Score: 0.013
  43. Association of Early Stress Testing with Outcomes for Emergency Department Evaluation of Suspected Acute Coronary Syndrome. Crit Pathw Cardiol. 2016 06; 15(2):60-8.
    View in: PubMed
    Score: 0.012
  44. Comparison of the HEART and TIMI Risk Scores for Suspected Acute Coronary Syndrome in the Emergency Department. Crit Pathw Cardiol. 2016 Mar; 15(1):1-5.
    View in: PubMed
    Score: 0.012
  45. Serial sampling of copeptin levels improves diagnosis and risk stratification in patients presenting with chest pain: results from the CHOPIN trial. Emerg Med J. 2016 Jan; 33(1):23-9.
    View in: PubMed
    Score: 0.012
  46. Midregional proadrenomedullin predicts mortality and major adverse cardiac events in patients presenting with chest pain: results from the CHOPIN trial. Acad Emerg Med. 2015 May; 22(5):554-63.
    View in: PubMed
    Score: 0.011
  47. Characteristics of patients that do not initially respond to intravenous antihypertensives in the emergency department: subanalysis of the CLUE trial. West J Emerg Med. 2015 Mar; 16(2):276-83.
    View in: PubMed
    Score: 0.011
  48. Sensitive troponin assays in patients with suspected acute coronary syndrome: Results from the multicenter rule out myocardial infarction using computer assisted tomography II trial. Am Heart J. 2015 Apr; 169(4):572-8.e1.
    View in: PubMed
    Score: 0.011
  49. A pilot study of implantable cardiac device interrogation by emergency department personnel. Crit Pathw Cardiol. 2014 Mar; 13(1):6-8.
    View in: PubMed
    Score: 0.011
  50. Quality of care for patients with acute coronary syndromes as a function of hospital revascularization capability: Insights from get with the guidelines-CAD. Clin Cardiol. 2014 May; 37(5):285-92.
    View in: PubMed
    Score: 0.010
  51. Body mass index and mortality in acutely decompensated heart failure across the world: a global obesity paradox. J Am Coll Cardiol. 2014 Mar 04; 63(8):778-85.
    View in: PubMed
    Score: 0.010
  52. Relationship of race/ethnicity with door-to-balloon time and mortality in patients undergoing primary percutaneous coronary intervention for ST-elevation myocardial infarction: findings from Get With the Guidelines-Coronary Artery Disease. Clin Cardiol. 2013 Dec; 36(12):749-56.
    View in: PubMed
    Score: 0.010
  53. Atrial fibrillation impairs the diagnostic performance of cardiac natriuretic peptides in dyspneic patients: results from the BACH Study (Biomarkers in ACute Heart Failure). JACC Heart Fail. 2013 Jun; 1(3):192-9.
    View in: PubMed
    Score: 0.010
  54. Validation of high-sensitivity troponin I in a 2-hour diagnostic strategy to assess 30-day outcomes in emergency department patients with possible acute coronary syndrome. J Am Coll Cardiol. 2013 Oct 01; 62(14):1242-1249.
    View in: PubMed
    Score: 0.010
  55. The association between self-reported exercise intensity and acute coronary syndrome in emergency department chest pain patients. J Emerg Med. 2013 Jan; 44(1):17-22.
    View in: PubMed
    Score: 0.010
  56. Mid-regional pro-adrenomedullin improves disposition strategies for patients with acute dyspnoea: results from the BACH trial. Emerg Med J. 2013 Aug; 30(8):633-7.
    View in: PubMed
    Score: 0.010
  57. 2-Hour accelerated diagnostic protocol to assess patients with chest pain symptoms using contemporary troponins as the only biomarker: the ADAPT trial. J Am Coll Cardiol. 2012 Jun 05; 59(23):2091-8.
    View in: PubMed
    Score: 0.009
  58. Influence of age, race, sex, and body mass index on interpretation of midregional pro atrial natriuretic peptide for the diagnosis of acute heart failure: results from the BACH multinational study. Eur J Heart Fail. 2012 Jan; 14(1):22-31.
    View in: PubMed
    Score: 0.009
  59. A 2-h diagnostic protocol to assess patients with chest pain symptoms in the Asia-Pacific region (ASPECT): a prospective observational validation study. Lancet. 2011 Mar 26; 377(9771):1077-84.
    View in: PubMed
    Score: 0.009
  60. Placental growth factor and B-type natriuretic peptide as independent predictors of risk from a multibiomarker panel in suspected acute coronary syndrome (Acute Risk and Related Outcomes Assessed With Cardiac Biomarkers [ARROW]) study. Am J Cardiol. 2011 Mar 15; 107(6):821-6.
    View in: PubMed
    Score: 0.008
  61. Serial changes in high-sensitive troponin I predict outcome in patients with decompensated heart failure. Eur J Heart Fail. 2011 Jan; 13(1):37-42.
    View in: PubMed
    Score: 0.008
  62. Acoustic cardiography S3 detection use in problematic subgroups and B-type natriuretic peptide "gray zone": secondary results from the Heart failure and Audicor technology for Rapid Diagnosis and Initial Treatment Multinational Investigation. Am J Emerg Med. 2011 Oct; 29(8):924-31.
    View in: PubMed
    Score: 0.008
  63. Mid-region pro-hormone markers for diagnosis and prognosis in acute dyspnea: results from the BACH (Biomarkers in Acute Heart Failure) trial. J Am Coll Cardiol. 2010 May 11; 55(19):2062-76.
    View in: PubMed
    Score: 0.008
  64. Adjusting for clinical covariates improves the ability of B-type natriuretic peptide to distinguish cardiac from non-cardiac dyspnoea: a sub-study of HEARD-IT. Eur J Heart Fail. 2009 Nov; 11(11):1043-9.
    View in: PubMed
    Score: 0.008
  65. Acute detection of ST-elevation myocardial infarction missed on standard 12-Lead ECG with a novel 80-lead real-time digital body surface map: primary results from the multicenter OCCULT MI trial. Ann Emerg Med. 2009 Dec; 54(6):779-788.e1.
    View in: PubMed
    Score: 0.008
  66. Low-risk acute heart failure patients: external validation of the Society of Chest Pain Center's recommendations. Crit Pathw Cardiol. 2009 Sep; 8(3):99-103.
    View in: PubMed
    Score: 0.008
  67. Emergency physician high pretest probability for acute coronary syndrome correlates with adverse cardiovascular outcomes. Acad Emerg Med. 2009 Aug; 16(8):740-8.
    View in: PubMed
    Score: 0.008
  68. S3 detection as a diagnostic and prognostic aid in emergency department patients with acute dyspnea. Ann Emerg Med. 2009 Jun; 53(6):748-57.
    View in: PubMed
    Score: 0.007
  69. Initial risk stratification and presenting characteristics of patients with evolving myocardial infarctions. Emerg Med J. 2008 Aug; 25(8):492-7.
    View in: PubMed
    Score: 0.007
  70. Design and rationale of the URGENT Dyspnea study: an international, multicenter, prospective study. Am J Ther. 2008 Jul-Aug; 15(4):299-303.
    View in: PubMed
    Score: 0.007
  71. ED patients with heart failure: identification of an observational unit-appropriate cohort. Am J Emerg Med. 2006 May; 24(3):319-24.
    View in: PubMed
    Score: 0.006
  72. The effect of treatment on the presence of abnormal heart sounds in emergency department patients with heart failure. Am J Emerg Med. 2006 Jan; 24(1):25-32.
    View in: PubMed
    Score: 0.006
  73. Insurance status and the treatment of myocardial infarction at academic centers. Acad Emerg Med. 2004 Apr; 11(4):343-8.
    View in: PubMed
    Score: 0.005
  74. The combination of enoxaparin, glycoprotein IIb/IIIa inhibitors and an early invasive approach among acute coronary syndrome patients. J Invasive Cardiol. 2004 Feb; 16(2):46-51.
    View in: PubMed
    Score: 0.005
  75. Comparison of troponin T versus creatine kinase-MB in suspected acute coronary syndromes. Am J Cardiol. 2000 Feb 15; 85(4):421-6.
    View in: PubMed
    Score: 0.004
  76. Efficacy of ketorolac tromethamine versus meperidine in the ED treatment of acute renal colic. Am J Emerg Med. 1999 Jan; 17(1):6-10.
    View in: PubMed
    Score: 0.004
  77. Clinical decision rules discriminate between fractures and nonfractures in acute isolated knee trauma. Ann Emerg Med. 1995 Oct; 26(4):429-33.
    View in: PubMed
    Score: 0.003
  78. Sensitivity of the Ottawa rules. Ann Emerg Med. 1995 Jul; 26(1):1-5.
    View in: PubMed
    Score: 0.003
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.